Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children.
HIV Paediatric Prognostic Markers Collaborative Study; Boyd K, Dunn DT, Castro H, Gibb DM, Duong T, Aboulker JP, Bulterys M, Cortina-Borja M, Gabiano C, Galli L, Giaquinto C, Harris DR, HugheS M, McKinney R, Mofenson L, Moye J, Newell ML, Pahwa S, Palumbo P, Rudin C, Sharland M, Shearer W, Thompson B, Tookey P. HIV Paediatric Prognostic Markers Collaborative Study, et al. Among authors: moye j. AIDS. 2010 May 15;24(8):1213-7. doi: 10.1097/QAD.0b013e3283389f41. AIDS. 2010. PMID: 20386428
Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Moye J Jr, Bethel J, Hirschhorn R, Jordan C, Nugent R. Mofenson LM, et al. Among authors: moye j jr. JAMA. 1992 Jul 22-29;268(4):483-8. doi: 10.1001/jama.268.4.483. JAMA. 1992. PMID: 1352363 Clinical Trial.
Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Bethel J, Moye J Jr, Flyer P, Nugent R. Mofenson LM, et al. Among authors: moye j jr. J Acquir Immune Defic Syndr (1988). 1993 Oct;6(10):1103-13. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8105072 Clinical Trial.
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Korelitz J, Meyer WA 3rd, Bethel J, Rich K, Pahwa S, Moye J Jr, Nugent R, Read J. Mofenson LM, et al. Among authors: moye j jr. J Infect Dis. 1997 May;175(5):1029-38. doi: 10.1086/516441. J Infect Dis. 1997. PMID: 9129063 Clinical Trial.
Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Yogev R, Korelitz J, Bethel J, Krasinski K, Moye J Jr, Nugent R, Rigau-Perez JG. Mofenson LM, et al. Among authors: moye j jr. Pediatr Infect Dis J. 1998 Oct;17(10):872-80. doi: 10.1097/00006454-199810000-00005. Pediatr Infect Dis J. 1998. PMID: 9802627
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Stiehm ER, Lambert JS, Mofenson LM, Bethel J, Whitehouse J, Nugent R, Moye J Jr, Glenn Fowler M, Mathieson BJ, Reichelderfer P, Nemo GJ, Korelitz J, Meyer WA 3rd, Sapan CV, Jimenez E, Gandia J, Scott G, O'Sullivan MJ, Kovacs A, Stek A, Shearer WT, Hammill H. Stiehm ER, et al. Among authors: moye j jr. J Infect Dis. 1999 Mar;179(3):567-75. doi: 10.1086/314637. J Infect Dis. 1999. PMID: 9952362 Clinical Trial.
Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Read JS, Bethel J, Harris DR, Meyer WA 3rd, Korelitz J, Mofenson LM, Moye J Jr, Pahwa S, Rich K, Nugent RP. Read JS, et al. Among authors: moye j jr. Pediatr Infect Dis J. 1999 Feb;18(2):134-42. doi: 10.1097/00006454-199902000-00010. Pediatr Infect Dis J. 1999. PMID: 10048685
Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Harris DR, Rich K, Meyer WA 3rd, Read JS, Moye J Jr, Nugent RP, Korelitz J, Bethel J, Pahwa S. Mofenson LM, et al. Among authors: moye j jr. AIDS. 1999 Jan 14;13(1):31-9. doi: 10.1097/00002030-199901140-00005. AIDS. 1999. PMID: 10207542 Clinical Trial.
327 results